Manolete Partners Plc (MANOF)

Ligand Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Manolete Partners had annual revenue of 30.48M GBP with 15.92% growth. Manolete Partners had revenue of 16.08M in the half year ending March 31, 2025, with 5.51% growth.

• Revenue: 30.48M GBP
• Revenue Growth: +15.92%
• P/S Ratio: 1.12
• Revenue / Employee: 1.05M GBP
• Employees: 29
• Market Cap: 44.05M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	30.48M	4.19M	15.92%
Mar 31, 2024	26.30M	5.54M	26.70%
Mar 31, 2023	20.75M	310.00K	1.52%
Mar 31, 2022	20.44M	-7.39M	-26.55%
Mar 31, 2021	27.83M	9.15M	48.98%